Liposome encapsulated irinotecan
Alternative Names: LE-CPT 11; Liposomal irinotecanLatest Information Update: 17 Dec 2021
At a glance
- Originator NeoPharm Inc
- Class Alkaloids; Antineoplastics; Camptothecins; Carboxylic acids; Esters; Indolizines; Piperidines; Pyrans; Quinolines; Small molecules
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 14 Oct 2003 No development reported - Preclinical for Cancer in USA (unspecified route)
- 29 Jan 2002 Preclinical development for Cancer in USA (unspecified route)